NYSE: PGProcter & Gamble Co Stock
$173.82-2.21 (-1.26%)
Updated Dec 6, 2024
PG Price
$173.82
Fair Value Price
N/A
Market Cap
$409.35B
52 Week Low
$142.50
52 Week High
$180.43
P/E
29.26x
P/B
7.9x
P/S
4.86x
PEG
2.86x
Dividend Yield
2.28%
Revenue
$83.91B
Earnings
$14.32B
Gross Margin
51.4%
Operating Margin
22.59%
Profit Margin
17.1%
Debt to Equity
1.43
Operating Cash Flow
$19B
Beta
0.55
Next Earnings
Jan 21, 2025
Ex-Dividend
N/A
Next Dividend
N/A
PG Overview
The Procter & Gamble Company offersbranded consumer packaged goods in the U.S. and internationally. It operates five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. It well-known brands include Head & Shoulders, Herbal Essences, Pantene, Rejoice, Olay, Old Spice, Safeguard, Secret, SK-II, Braun, Gillette, Venus, Crest, Oral-B, Metamucil, Neurobion, Pepto-Bismol, Vicks, Ariel, Downy, Gain, and Tide. Procter & Gamble was founded in 1837 and is headquartered in Cincinnati, OH.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine PG's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Value
D
Growth
C
Momentum
C
Sentiment
A
Safety
B
Financials
C
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Household & Personal Product
Industry Rating
B
PG
Ranked#14 of 25
Ranked#14 of 25
Be the first to know about important PG news, forecast changes, insider trades & much more!
PG News
Overview
Due Diligence Score
–
Industry Average (37)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how PG scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
PG ($173.82) is trading above its intrinsic value of $55.01, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
PG is good value based on its earnings relative to its share price (29.26x), compared to the US market average (29.86x)
P/E vs Market Valuation
PG is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more PG due diligence checks available for Premium users.
Valuation
PG price to earnings (PE)
For valuing profitable companies with steady earnings
Company
29.26x
Industry
32.87x
Market
29.86x
PG is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
PG is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
PG price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
7.9x
Industry
7.51x
PG is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
PG price to earnings growth (PEG)
For valuing profitable companies with growth potential
PG is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
PG's financial health
Profit margin
Revenue
$21.7B
Net Income
$4.0B
Profit Margin
18.2%
PG's Earnings (EBIT) of $18.95B... subscribe to Premium to read more.
Interest Coverage Financials
PG's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$126.5B
Liabilities
$74.3B
Debt to equity
1.43
PG's short-term liabilities ($36.42B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PG's long-term liabilities ($37.92B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PG's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
PG's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$4.3B
Investing
-$1.1B
Financing
-$634.0M
PG's operating cash flow ($19.24B)... subscribe to Premium to read more.
Debt Coverage Financials
PG vs Household & Personal Product Stocks
Procter & Gamble Co Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.